New analytical techniques developed to quantify composition of fake anti-malarialsJune 14, 2006Researchers led by the Georgia Institute of Technology are developing novel analytical chemistry techniques to detect and quantify the contents of counterfeit anti-malarial drugs and other fake pharmaceuticals. The manufacture and distribution of these fake medications is a growing problem in third-world countries, where the mosquito-borne illness malaria is widespread. A report on this research — funded by the Society of Analytical Chemists of Pittsburgh and the Wellcome Trust of Great Britain — will be published this summer in the journal ChemMedChem. Georgia Tech Assistant Professor of Chemistry and Biochemistry Facundo Fernandez began studying counterfeit anti-malarials two years ago using conventional analytical chemistry techniques based on liquid chromatography and mass spectrometry. But these methods required more than two hours to analyze just one sample. So he and his graduate students developed new, high-throughput ionization techniques that now allow them to complete the same analytical analyses in just five seconds per sample. "This is a new generation of techniques in mass spectrometry," Fernandez said. "We don't probe our samples under vacuum like you normally do with mass spectrometry. We can hold a solid sample under atmospheric pressure and use one of our new tools to ionize its surface components. The ionized particles are subsequently analyzed by mass spectrometry. This method eliminates the time and costs associated with sample preparation." Specifically, Fernandez and his students have worked to improve two recently developed analytical chemistry techniques — desorption electrospray ionization (DESI) developed by Purdue University and direct analysis in real time (DART) developed by the Japanese company JEOL. The researchers use DESI to screen anti-malarials to quantify the amount of the active ingredient artesunate in counterfeits. In DESI, researchers use a high-speed, charged spray containing alcohol and water. Typically, this solvent mixture reacts with a solid sample, such as a tablet, picking up molecules from its surface and transferring them to a detector. But artesunate is a relatively unstable molecule that fragments easily and causes DESI to lose its sensitivity. So Fernandez and his students have now added an alkylamine compound to the alcohol-water mixture to form a stable molecular species, preventing artesunate fragmentation and thereby increasing sensitivity. They call this process "reactive DESI." DART, on the other hand, involves an ionizing beam of marginally stable helium atoms generated by an electric discharge. The DART ionization mechanism is still not completely understood. In ongoing research, Fernandez and his students are working to interface DART with other instruments to help understand the chemistry behind the methodology. To date, they have interfaced DART with a mass spectrometer, but the latter is typically too bulky and expensive to use in a field setting. So researchers plan to interface DART with a similar instrument called an ion mobility spectrometer (IMS), which is used in airports to detect explosives. They hope the pair of techniques could be used in the field to screen solid samples of anti-malarial drugs. "Our findings not only demonstrate the usefulness of DART for rapid screening of counterfeit drugs, but also have unprecedented implications for malaria control," Fernandez and his co-authors report in ChemMedChem. "We foresee that both DART and DESI will have a tremendous impact in a variety of scientific fields, ranging from drug quality control, screening and discovery to biological applications, such as metabonomics and/or proteomics." Georgia Institute of Technology Research News |
|||||||||||||||||||||
| Related Anti-malarial Current Events and Anti-malarial News Articles New research confirms potential deadly nature of emerging new monkey malaria species in humans Researchers in Malaysia have identified key laboratory and clinical features of an emerging new form of malaria infection. Unique immunization method provides insights about protective anti-malaria immune response In this week's New England Journal of Medicine, scientists in Singapore, The Netherlands and France report that they have developed a novel immunization method that will induce fast and effective protection in humans against the life-threatening malaria parasite, Plasmodium falciparum, which infects 350 to 500 million people world-wide and kills over one million people each year. Tryptophan deficiency may underlie quinine side effects Researchers have found that the anti-malarial drug quinine can block a cell's ability to take up the essential amino acid tryptophan, a discovery that may explain many of the adverse side-effects associated with quinine. Researchers identify genes for thiostrepton, a powerful drug whose use is now limited Researchers at the Georgia Institute of Technology have identified the genetic machinery responsible for synthesizing thiostrepton, a powerful antibiotic produced by certain bacteria. Though effective against the dangerous MRSA (methicillin-resistant Staphylococcus aureus) and vancomycin-resistant enterococci, thiostrepton currently has only limited applications in humans because it is not water soluble. Synthetic Biology Can Help Extend Anti-Malaria Drug Effectiveness In addition to providing a simple and much less expensive means of making artemisinin, the most powerful anti-malaria drug in use today, synthetic biology can also help to extend the effectiveness of this drug. Fermenting artemisinin via engineered microbes, such as yeast, can be done at far lower costs than extracting the drug from Artemsisia annua, the sweet wormwood tree, making microbial-based artemisinin a much cheaper but equally effective treatment. Tools for more accurate dosage of drugs against HIV/AIDS and malaria A doctoral thesis presented at the Sahlgrenska Academy, University of Gothenburg, Sweden, shows that it is possible to describe and quantify the relationships between dose, concentration and effectiveness of several drugs against HIV/AIDS and malaria. The method may allow improved treatment and fewer undesired effects for patients with these diseases. Applying 'supply and demand' business principles to treat infectious diseases worldwide Treating infectious diseases while meeting escalating costs to do so continues to pose worldwide challenges, with one of the main issues being the ability to provide an adequate supply of drugs to treat infectious diseases. New way to make malaria medicine also first step in finding new antibiotics University of Illinois microbiology professor William Metcalf and his collaborators have developed a way to mass-produce an antimalarial compound, potentially making the treatment of malaria less expensive. Bio-imaging mass spectrometry techniques reveal molecular details about complex systems Understanding biology at the systems level is difficult, especially when studying complex specimens like tissue slices or communities of organisms in a biofilm. Scientists must be able to identify, quantify and locate the molecules present in the samples. Study: Delaying evolution of drug resistance in malaria parasite possible There's no magic bullet for wiping out malaria, but a new study offers strong support for a method that effectively delays the evolution of drug resistance in malaria parasites, a University of Florida researcher says. More Anti-malarial Current Events and Anti-malarial News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||